Nasal Delivery Devices Market Size, Share, Growth Report 2032

Nasal Delivery Devices Market

Nasal Delivery Devices Market – By Drug Type (Anesthetics, Antibiotics, Pain Relief Drugs, Calcium Supplements, Vasoconstrictors, and Antihistamines); By Technologies (Spray, Nebulizers, and Inhalers); By End-User (Home Care, Settings, Hospitals, and Clinics), and by Region¬–Global Industry Analysis, Size, Share, Growth, Trends, And Forecast, 2020-2026

Category: Medical Device Report Format : PDF Pages: 142 Report Code: ZMR-6205 Published Date: May-2021 Status : Published

The global Nasal Delivery Devices Market Size Was Worth 57.1 (USD Billion) in 2019 and Is Expected To Reach 80.1 (USD Billion) by 2026, CAGR of 6.1%.

Nasal Delivery Devices Market Size And Industry Analysis

The global Nasal Delivery Devices Market Size, which was estimated at 57.1 (USD Billion) in 2019 and is anticipated to accrue earnings worth 80.1 (USD Billion) by 2026, is set to record a CAGR of nearly 6.1% over 2020-2026. The report offers a valuation and analysis of the Nasal Delivery Devices market on a global as well as regional level. The study offers a comprehensive assessment of the industry competition, limitations, sales estimates, avenues, current & emerging trends, and industry-validated market data. The report offers historical data from 2016 to 2019 along with a forecast from 2020 to 2026 based on value (USD Billion).

Global Nasal Delivery Devices Market SizeRequest Free Sample

To know more about this report, Request A Sample Copy.

Nasal Delivery Devices Market: Introduction

Nasal delivery is the rational choice for topical treatment of nose & paranasal sinuses including allergic & non-allergic rhinitis as well as sinusitis. Apart from this, the nose is a key path for systemic medicine delivery and needle-free vaccination. Moreover, nasal delivery equipment addresses concerns pertaining to slow absorption, adverse activities in the gastrointestinal tract, poor bioavailability, prevents first-pass metabolism in the liver, drug degradation, and slow absorption. Apparently, the nasal delivery device is a highly popular drug delivery route among healthcare service providers & patients.

Nasal Delivery Devices Market: Growth Drivers

The growth of the nasal delivery devices industry over the forecast period can be attributed to its non-invasive features and huge medicine absorption through the nasal route. Apart from this, easy administration of the medicines in the patient has played a key role in enhancing the compliance of drug treatments in patients, thereby driving the market trends. Furthermore, the surge in the cases of brain disorders is anticipated to enhance the demand for nasal delivery devices. In addition to this, many scientific research papers have supported the use of drug delivery through nasal equipment as the latter facilitates the high permeability of medicines through blood-brain drainers. This, in turn, will steer the business growth over the forecast timeline. In addition to this, the escalating occurrence of respiratory ailments as well as neurological diseases will boost the use of the nasal delivery devices industry.

Nasal Delivery Devices Market Report Scope:

Report Attributes Report Details
Report Name Nasal Delivery Devices Market Research Report
Market Size in 2019 USD 57.1 Billion
Market Forecast in 2026 USD 80.1 Billion
Compound Annual Growth Rate CAGR of 6.1%
Number of Pages 142
Forecast Units Value (USD Billion), and Volume (Units)
Key Companies Covered Novartis AG; GlaxoSmithKline plc.; Merck & Co. Inc.; AstraZeneca; Pfizer Inc.; BD; Dr. Reddy's Laboratories; Sanofi; Cadila Pharmaceuticals Ltd.; and Neurelis, Inc.
Segments Covered By Drug Type, By Technologies, By End User, And By Region
Regions Covered North America, Europe, Asia Pacific (APAC), Latin America, Middle East, and Africa (MEA)
Countries Covered North America: U.S and Canada
Europe: Germany, Italy, Russia, U.K, Spain, France, Rest of Europe
APAC: China, Australia, Japan, India, South Korea, South East Asia, Rest of Asia Pacific
Latin America: Brazil, Argentina, Chile
The Middle East And Africa: South Africa, GCC, Rest of MEA
Base Year 2021
Historical Year 2016 to 2020
Forecast Year 2022 - 2030
Customization Scope Avail customized purchase options to meet your exact research needs. Request For Customization

Nasal Delivery Devices Market: Regional Landscape

North American Market To Steer Nasal Delivery Devices Market Size By 2026

The expansion of the nasal delivery devices industry over 2020-2026 can be credited to a rise in the number of CNS tumors among children aged between 0 to 14. The surge in respiratory tract infections, TB, COPD, lung cancer, and asthma in the region will prompt market growth in the sub-continent in the years to come. Unhealthy lifestyles, high tobacco inhalation, and growing pollution due to urbanization & industrialization in U.S. and Canada will culminate into a massive regional market surge over 2020-2026.

Competitive Landscape

Key players profiled in the report include 

  • Novartis AG
  • GlaxoSmithKline plc.
  • Merck & Co. Inc.
  • AstraZeneca
  • Pfizer Inc.
  • BD
  • Dr. Reddy's Laboratories
  • Sanofi
  • Cadila Pharmaceuticals Ltd.
  • Neurelis, Inc.

The global Nasal Delivery Devices Market is segmented as follows:

By Drug Type

  • Anesthetics
  •  Antibiotics
  •  Pain Relief Drugs
  •  Calcium Supplements
  •  Vasoconstrictors
  •  Antihistamines
  •  Others

By Technologies

  • Spray
  • Nebulizers
  • Inhalers

By End User

  • Home Care
  • Settings
  • Hospitals
  • Clinics

By Region

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table Of Content

Methodology

FrequentlyAsked Questions

The growth of nasal delivery devices industry over the forecast period can be attributed to its non-invasive features and huge medicine absorption through nasal route. Apart from this, easy administration of the medicines in the patient has played a key role in enhancing the compliance of drug treatments in patients, thereby driving the market trends. Furthermore, surge in the cases of brain disorders is anticipated to enhance the demand for nasal delivery devices. In addition to this, many of the scientific research papers have supported the use of drug delivery through nasal equipment as the latter facilitates high permeability of medicines through blood brain drainer. This, in turn, will steer the business growth over the forecast timeline. In addition to this, the escalating occurrence of respiratory ailments as well as neurological diseases will boost the use of nasal delivery devices industry.

According to Zion Market Research report, the global Nasal Delivery Devices Market, which was estimated at 57.1(USD Billion) in 2019 and is anticipated to accrue earnings worth 80.1(USD Billion) by 2026, is set to record a CAGR of nearly 6.1% over 2020-2026.

North America is likely to make noteworthy contributions towards overall market revenue. The growth of the industry in the sub-continent over the estimated timespan is attributed to rise in the number of CNS tumors among the children aged between 0 to 14. Surge in the respiratory tract infections, TB, COPD, lung cancer, and asthma in the region will prompt the market growth in the sub-continent in the years to come. Unhealthy lifestyle, high tobacco inhalation, and growing pollution due to urbanization & industrialization in U.S. and Canada will culminate into massive regional market surge over 2020-2026.

The key players profiled in the report include are Novartis AG; GlaxoSmithKline plc.; Merck & Co. Inc.; AstraZeneca; Pfizer Inc.; BD; Dr. Reddy's Laboratories; Sanofi; Cadila Pharmaceuticals Ltd.; and Neurelis, Inc.

Choose License Type

  • zion payment modes

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

Contact #

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Industry Press Release

We Accept

We have secured system to process your transaction.

  • payment methods

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed